Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Intensity Therapeutics Says The First Few Patients Receiving INT230-6 Achieved High Levels Of Necrosis After Eight Days In Phase 2 INVINCIBLE-4 Study Prior To Start Of Standard-of-Care

Author: Benzinga Newsdesk | June 11, 2025 08:42am

Posted In: INTS